Web Analytics

fundsforNGOs

Grants and Resources for Sustainability

You are here: Home / Innovation / EC: Programme Level Collaboration between National R&I Policy-Makers

EC: Programme Level Collaboration between National R&I Policy-Makers

Deadline: 9-Mar-23

The European Commission (EC) is inviting applications for the Programme Level Collaboration between National Research and Innovation (R&I) Policy-Makers under the Horizon Europe Framework Programme (HORIZON).

Objectives
  • To address these requirements, Destination 3 of part 11 of the Horizon Europe work programme will support efforts to reform and enhance the European R&I system. Destination 3 is built around four strands corresponding to the four objectives set out in the ERA Communication:

    • Prioritising investments and reforms in research and innovation;
    • Improving access to excellence, progressing towards excellence across the whole EU and striving for stronger research and innovation systems;
    • Translating R&I results into the economy to meet the digital and green transition objectives, and boost the resilience and competitiveness of our economies and societies;
    • Deepening the ERA, to further progress the free circulation of knowledge and to ensure an upgraded, efficient and effective R&I system.
  • The principle of excellence, meaning that the best researchers with the best ideas that offer the best solutions to the societal challenges obtain funding, remains the cornerstone for all investments under the ERA.
Scope
  • Since the introduction of the European Research Area (ERA) in 2000 and starting with Framework Programme 6 and the introduction of the ERA-NET scheme, programme level collaboration among Member States and Associated Countries and their research and innovation funding programmes has become a cornerstone of the ERA, with annual investment from Member States of more than EUR 800 million per year. More than 250 networks among research funders have been created over time, serving different research needs but always coordinating public research investments across borders and allowing researchers to apply for calls for transnational research projects funded by the participating states.
  • Horizon Europe introduces a new approach to incentivise programme level collaboration by identifying upfront candidate European co-funded, co-programmed and institutionalised partnerships in the Strategic Plan. The first Strategic Plan also identified 5 EU missions to be supported through Horizon Europe.
  • Co-funding to R&I partnerships of European relevance is under Horizon Europe limited to European Partnerships identified in the Strategic Plan for Horizon Europe.
  • The ERA part of Horizon Europe complements this new strategic approach by providing the possibility for Member States, Associated Countries and civil society organisations such as foundations, to maintain existing and establish new collaborations on priorities of their choice, thereby continuing the spirit of the successful ERA-NET scheme, and extending it also to the domain of EU missions.
  • Successful proposals should align national and regional research funding programmes on agreed priorities that are common to the countries participating in the action and, where appropriate, implement joint calls for transnational R&I projects as well as other joint calls or other joint activities. Applicants should demonstrate clear commitments from participating programmes to pool resources and ensure complementarity between activities and policies with those of the Framework Programme and relevant European Partnerships and EU missions.
  • Proposals should pool the necessary resources from the participating national (or regional) research programmes as well as, where appropriate, leverage resources from pertinent foundations, charities and transnational initiatives, with a view to implementing calls for proposals, either within the context of this action or in possible follow-up actions, resulting in grants to third parties without EU co-funding in this area.
  • The proposals should also demonstrate potential impact at national, regional and transnational level. The proposals should demonstrate that activities exclude overlaps with on-going actions co-funded by the EU under Horizon 2020 or Horizon Europe.
  • The actions should envisage a duration appropriate to the ambition and complexity of the proposed topic.
Funding Information

The check will normally be done for the coordinator if the requested grant amount is equal to or greater than EUR 500 000, except for:

  • public bodies (entities established as a public body under national law, including local, regional or national authorities) or international organisations; and
  • cases where the individual requested grant amount is not more than EUR 60 000 (lowvalue grant).
Expected Outcome

Projects are expected to contribute to all of the following expected outcomes:

  • The actions funded under this topic will coordinate national and regional R&I funding programmes by pooling national resources and contributing to the alignment of national research and innovation policies. The expected outcomes:

    • Identification of common research and innovation priorities agreed among the participating national and regional R&I programmes, taking into account international developments where relevant and leading to the development of coordinated R&I funding agendas;
    • Implementation of multiannual joint calls, resulting in the funding of transnational collaborative R&I projects;
    • Implementation of other joint activities supporting technology development, market introduction, regulatory aspects and societal uptake of results;
    • Contribution to participating states meeting Global Challenges, including relevant contributions to the SDGs.
Eligible Activities
  • Eligible activities are the ones described in the call conditions. Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.
  • Projects must focus exclusively on civil applications and must not:

    • aim at human cloning for reproductive purposes;
    • intend to modify the genetic heritage of human beings which could make such changes heritable (except for research relating to cancer treatment of the gonads, which may be financed);
    • intend to create human embryos solely for the purpose of research, or for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer.
  • Projects must, moreover, comply with EU policy interests and priorities (environment, social, security, industrial policy, etc.).
  • The following activities are generally eligible for grants under Horizon Europe:

    • Research and innovation actions (RIA) — Activities that aim primarily to establish new knowledge or to explore the feasibility of a new or improved technology, product, process, service or solution. This may include basic and applied research, technology development and integration, testing, demonstration and validation of a small-scale prototype in a laboratory or simulated environment.
    • Innovation actions (IA) — Activities that aim directly to produce plans and arrangements or designs for new, altered or improved products, processes or services. These activities may include prototyping, testing, demonstrating, piloting, large-scale product validation and market replication.
    • Coordination and support actions (CSA) — Activities that contribute to the objectives of Horizon Europe. This excludes research and innovation (R&I) activities, except those carried out under the ‘Widening participation and spreading excellence’ component of the programme.
    • Programme co-fund actions (CoFund) — A programme of activities established or implemented by legal entities managing or funding R&I programmes, other than EU funding bodies. Such a programme of activities may support: networking and coordination; research; innovation; pilot actions; innovation and market deployment; training and mobility; awareness raising and communication; and dissemination and exploitation.
    • Innovation and market deployment actions (IMDA) — Activities that embed an innovation action and other activities necessary to deploy an innovation on the market. This includes the scaling-up of companies and Horizon Europe blended finance.
    • Training and mobility actions (TMA) — Activities that aim to improve the skills, knowledge and career prospects of researchers, based on mobility between countries and, if relevant, between sectors or disciplines.
    • Pre-commercial procurement actions (PCP) — Activities that aim to help a transnational buyers’ group to strengthen the public procurement of research, development, validation and, possibly, the first deployment of new solutions that can significantly improve quality and efficiency in areas of public interest, while opening market opportunities for industry and researchers active in Europe. Eligible activities include the preparation, management and follow-up, under the coordination of a lead procurer, of one joint PCP and additional activities to embed the PCP into a wider set of demand-side activities.
    • Public procurement of innovative solutions actions (PPI) — Activities that aim to strengthen the ability of a transnational buyers’ group to deploy innovative solutions early by overcoming the fragmentation of demand for such solutions and sharing the risks and costs of acting as early adopters, while opening market opportunities for industry. Eligible activities include preparing and implementing, under the coordination of a lead procurer, one joint or several coordinated PPI by the buyers’ group and additional activities to embed the PPI into a wider set of demand-side activities.
Eligibility Criteria
  • Any legal entity, regardless of its place of establishment, including legal entities from nonassociated third countries or international organisations (including international European research organisations) is eligible to participate (whether it is eligible for funding or not), provided that the conditions laid down in the Horizon Europe Regulation have been met, along with any other conditions laid down in the specific call topic.
  • A ‘legal entity’ means any natural or legal person created and recognised as such under national law, EU law or international law, which has legal personality and which may, acting in its own name, exercise rights and be subject to obligations, or an entity without legal personality.
  • Beneficiaries and affiliated entities must register in the Participant Register before submitting their application, in order to get a participant identification code (PIC) and be validated by the Central Validation Service before signing the grant agreement. For the validation, they will be asked to upload the necessary documents showing their legal status and origin during the grant preparation stage. A validated PIC is not a prerequisite for submitting an application.
  • Specific Cases

    • Affiliated entities — Affiliated entities (i.e. entities with a legal or capital link to a beneficiary which participate in the action with similar rights and obligations to the beneficiaries, but which do not sign the grant agreement and therefore do not become beneficiaries themselves) are allowed, if they are eligible for participation and funding.
    • Associated partners — Associated partners (i.e. entities which participate in the action without signing the grant agreement, and without the right to charge costs or claim contributions) are allowed, subject to any conditions regarding associated partners set out in the specific call conditions.
    • Entities without legal personality — Entities which do not have legal personality under their national law may exceptionally participate, provided that their representatives have the capacity to undertake legal obligations on their behalf, and offer guarantees to protect the EU’s financial interests equivalent to those offered by legal persons.
    • EU bodies — Legal entities created under EU law including decentralised agencies may be part of the consortium, unless provided for otherwise in their basic act.
  • To become a beneficiary, legal entities must be eligible for funding.
  • To be eligible for funding, applicants must be established in one of the following countries:

    • the Member States of the European Union, including their outermost regions: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
    • the Overseas Countries and Territories (OCTs) linked to the Member States: Aruba (NL), Bonaire (NL), Curação (NL), French Polynesia (FR), French Southern and Antarctic Territories (FR), Greenland (DK), New Caledonia (FR), Saba (NL), Saint Barthélemy (FR), Sint Eustatius (NL), Sint Maarten (NL), St. Pierre and Miquelon (FR), Wallis and Futuna Islands (FR).
    • countries associated to Horizon Europe; Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine.

For more information, visit EC.